14 ott - Italia
Quetzaltx
pQuetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also developing a pre-clinical asset QTX-2102, an advanced, next-generation antifungal and antiparasitic therapy designed to enhance efficacy while minimizing toxicity. Our mission is to push the boundaries of treatment possibilities, delivering hope and life-changing solutions to those who need them most. /p h3Contractor Medical Science Liaison (MSL) – Italy/Germany Territory /h3 h3Haematology / Oncology – Phase 3 Clinical Trial Support /h3 h3Role Overview /h3 pWe are seeking an experienced contractor Medical Science Liaison (MSL) to support a multinational Phase 3 haematology/oncology clinical trial across Italy and Germany. This field-based role will focus on scientific engagement with investigators and treatment centres, supporting trial awareness, operational engagement, and high-quality scientific exchange within a compliant framework. /p pThe successful candidate will work independently across a geographically distributed territory and act as a key scientific interface between the company and external stakeholders. /p h3Territory Coverage /h3 pPrimary territories: /p ulliItaly /liliGermany /li /ul pTravel within the assigned territory and attendance at relevant scientific meetings/congresses will be required. /p h3Time in Field /h3 pApproximately 70–80% field-focused activity expected. /p h3Key Responsibilities /h3 ulliDevelop and maintain scientific relationships with investigators, referral centres,
and relevant healthcare professionals /liliSupport scientific engagement around an ongoing Phase 3 haematology clinical trial /liliDeliver high-quality, non-promotional scientific exchange in compliance with applicable regulations and company SOPs /liliSupport trial awareness and operational engagement activities within assigned territories /liliIdentify and communicate field insights, including recruitment challenges, treatment landscape developments, and investigator feedback /liliSupport congress activities, investigator meetings, and scientific discussions as required /liliEnsure timely and accurate documentation of activities and reporting of adverse events/product complaints in accordance with pharmacovigilance requirements /liliWork cross-functionally with Medical Affairs, Clinical Operations, and other internal stakeholders /li /ul h3Required Qualifications Experience /h3 ulliAdvanced scientific or healthcare degree (PharmD, PhD, MD, MSc or equivalent) /liliPrior experience as a field-based MSL within oncology or haematology /liliStrong scientific acumen and ability to communicate complex clinical data effectively /liliDemonstrated ability to work independently across a multi-site territory /liliExperience developing relationships with academic investigators and healthcare professionals /liliStrong communication, presentation, and stakeholder engagement skills /liliExperience working within GCP, pharmacovigilance, and compliance frameworks /liliExperience within Italy and/or Germany is essential /li /ul h3Strongly Preferred /h3 ulliItalian language proficiency strongly preferred /liliPrior experience in haematology and/or rare cancers /liliExperience supporting Phase 2 or Phase 3 clinical trials /liliExperience supporting recruitment or referral engagement activities for clinical trials /liliExisting relationships within relevant haematology treatment centres /liliExperience working in multinational European territories /li /ul h3Working Model /h3 ulliField-based role /liliTravel required across assigned territories /li /ul #J-18808-Ljbffr
15 ott - Cremona
Amplifon
15 ott - Pieve di Cadore
LHH
15 ott - Macerata
Adecco Talent Attraction
15 ott - Aviano
Reach Aut